250 related articles for article (PubMed ID: 12748249)
1. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
3. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
4. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
[TBL] [Abstract][Full Text] [Related]
5. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
[TBL] [Abstract][Full Text] [Related]
7. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
8. No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis.
Ryan A; Al-Jehani RM; Mulligan KT; Jacobs IJ
Gynecol Oncol; 1998 Jan; 68(1):14-7. PubMed ID: 9454653
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
Kim YJ; Jung JK; Lee SY; Jang KL
Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
11. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.
García JF; Villuendas R; Algara P; Sáez AI; Sánchez-Verde L; Martínez-Montero JC; Martínez P; Piris MA
Lab Invest; 1999 Dec; 79(12):1453-9. PubMed ID: 10616196
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
[TBL] [Abstract][Full Text] [Related]
15. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas.
Huang MJ; Yeh KT; Shih HC; Wang YF; Lin TH; Chang JY; Shih MC; Chang JG
Int J Mol Med; 2002 Nov; 10(5):551-4. PubMed ID: 12373290
[TBL] [Abstract][Full Text] [Related]
16. Hepatoblastomas exhibit marked
Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of p16 by CpG hypermethylation in renal cell carcinoma.
Vidaurreta M; Maestro ML; Sanz-Casla MT; Maestro C; Rafael S; Veganzones S; Moreno J; Blanco J; Silmi A; Arroyo M
Urol Oncol; 2008; 26(3):239-45. PubMed ID: 18452812
[TBL] [Abstract][Full Text] [Related]
19. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
20. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
